Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • blood (2)
  • child (1)
  • cohort (1)
  • dystocia (1)
  • female (1)
  • history birth (1)
  • humans (1)
  • macrosomia (1)
  • odds ratio (1)
  • plasma (1)
  • preeclampsia (1)
  • pregnancy (1)
  • prognostic (1)
  • risk factors (12)
  • screen (1)
  • women (4)
  • Sizes of these terms reflect their relevance to your search.

    We aimed to evaluate a selective screening strategy for gestational diabetes mellitus (GDM) based on the presence of risk factors: BMI ≥25 kg/m(2), age ≥35 years, family history of diabetes, personal history of GDM, or birth of a child with macrosomia. Of 20,630 deliveries between 2002 and 2010, we selected 18,775 deliveries in women with no known diabetes and for whom all risk factors were known. GDM was universally screened and defined as fasting plasma glucose level ≥5.3 mmol/L and/or 2-h postload (75 g) glucose level ≥7.8 mmol/L. The prevalence of at least one risk factor has increased since 2002 (P < 0.001) from 51.7 to 61.5%, with no change in the GDM prevalence (mean 14.4%, intention to screen). At least one risk factor was present in 58.5% of women who represented 65.3% of all those with GDM. The presence of risk factors was significantly associated with GDM (odds ratio 1.4 [95% CI 1.3-1.5], P < 0.001) and with GDM-related events (preeclampsia/large for gestational age/dystocia) (P < 0.001) with the following incidences: no GDM/no risk factor 8.8%, no GDM/risk factor 11.1%, GDM/no risk factor 16.7%, and GDM/risk factor 18.2%. The presence of risk factors increased during the last decade. This condition is predictive of GDM and GDM-related events. However, a selective screening would lead to missing one-third of the women with GDM who, even without risk factors, had more events than women without GDM. Therefore, these data stand against the present selective screening currently proposed in the French guidelines.

    Citation

    Emmanuel Cosson, Amélie Benbara, Isabelle Pharisien, Minh Tuan Nguyen, Aurélie Revaux, Boris Lormeau, Dorian Sandre-Banon, Nabil Assad, Camille Pillegand, Paul Valensi, Lionel Carbillon. Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18,775 subjects. Diabetes care. 2013 Mar;36(3):598-603

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 23150287

    View Full Text